Efficacy of Psychotherapy for Improving Quality of Life in Patients With Hypertrophic Cardiomyopathy and Depression

Air Force Military Medical University of People's Liberation Army

Status

Unknown

Conditions

Psychotherapy

Depression

Anxiety

Hypertrophic Cardiomyopathy

Treatments

Other: Psychotherapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03706001

KY20182033-1

Details and patient eligibility

About

A Study to evaluate the efficacy of psychotherapy for easing the cardiac symptoms and improving and quality of life in patients with hypertrophic cardiomyopathy accompanied with depression

Full description

This study will use a 8 week parallel group design. 100 patients diagnosed as hypertrophic cardiomyopathy accompanied with depression will be into experimental group and control group. The experimental group received 8 times of psychological treatments for once each week; the control group did not receive any antidepressant treatment. Follow-up assessments will be performed at baseline, week 4 and 8.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnosed as hypertrophic cardiomyopathy;
Diagnosed as depression;

Exclusion criteria

Patients with left ventricular ejection fraction (EF) ≦ 30%;
Renal dysfunction with serum creatinine ≧451umol/l;
Severe heart failure and New York Heart Association (NYHA) Heart Failure Grade III;
Combine with any type of malignant tumor;
Combine with other serious mental illnesses such as bipolar disorder, schizophrenia, schizophrenia-like illness, severe dementia, etc.;
Have received medication of antidepressant or psychotherapy;
Patients with major depression; Patients with a serious risk of suicide or have had suicide attempts;
Pregnant women and lactating women, or women who are planning to become pregnant or breastfeeding during the study period;
Other circumstances in which the researcher judges that it is not suitable as a research object.